Artificial Intelligence (AI) is making significant strides in various fields, and drug development is no exception. While AI's applications in text generation, facial recognition, and autonomous driving are well-known, its potential in drug discovery is equally transformative, promising to save
CAR-T cell therapy has emerged as a groundbreaking approach in cancer treatment, leveraging the body's immune system to target and destroy cancer cells. Since its inception in 2017, this innovative therapy has rapidly evolved, with numerous products reaching commercialization and receiving
Chronic obstructive pulmonary disease (COPD) is a progressive respiratory condition that profoundly impacts patients' quality of life and incurs substantial healthcare costs. Effective management of COPD often necessitates the use of inhaled medications, such as corticosteroids, long-acting
Gene therapy has emerged as a promising frontier for treating a range of genetic disorders, but effectively delivering therapeutic genes to the kidneys remains a significant challenge. Researchers at the Oregon Health & Science University School of Medicine have been delving into the complex domain
The role of artificial intelligence (AI) in drug discovery and development has been a topic of increasing interest and debate, with many experts heralding its promise to transform the process by reducing time and costs significantly. Amid the excitement, however, there remain substantial challenges
The groundbreaking exploration of mRNA vaccines, most notably recognized for their pivotal role in combating the COVID-19 pandemic, has far-reaching implications that extend beyond infectious disease management into the realm of oncology. Researchers at Memorial Sloan Kettering Cancer Center
